{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:26:30Z","timestamp":1773890790476,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T00:00:00Z","timestamp":1196726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11239-007-0105-x","type":"journal-article","created":{"date-parts":[[2007,12,3]],"date-time":"2007-12-03T23:52:05Z","timestamp":1196725925000},"page":"18-25","source":"Crossref","is-referenced-by-count":20,"title":["Anticoagulation for mechanical heart valves: a role for patient based therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Robert W.","family":"Emery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann. M.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goya V.","family":"Raikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay G.","family":"Shake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,4]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valves prostheses. Circulation 89:635\u2013641","journal-title":"Circulation"},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-5223(19)41305-6","volume":"75","author":"LD Joyce","year":"1978","unstructured":"Joyce LD, Emery RW, Nicoloff DM (1978) Ball variance and fracture of mitral valve prosthesis causing recurrent thromboemboli. J Thorac Cardiovasc Surg 75:309\u2013312","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR3","first-page":"235","volume":"30","author":"RW Emery","year":"1979","unstructured":"Emery RW, Lindsay WG, Anderson RW, Jorgensen CR, Wang Y, Nicoloff DM (1979) Clinical and hemodynamic results with the St. Jude Medical aortic valve prosthesis. Surg Forum 30:235\u2013238","journal-title":"Surg Forum"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jtcvs.2004.08.023","volume":"129","author":"DD Potter","year":"2005","unstructured":"Potter DD, Sundt TM, Zehr KJ et\u00a0al (2005) Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg 129:94\u2013103","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl II","key":"105_CR5","first-page":"II-98","volume":"108","author":"WRE Jamison","year":"2003","unstructured":"Jamison WRE, Burr LH, Migagishima RT et\u00a0al (2003) Re-operation for bioprosthetic mitral structure failure: risk assessment. Circulation 108(Suppl II):II-98\u2013II-102","journal-title":"Circulation"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.athoracsur.2004.08.047","volume":"79","author":"RW Emery","year":"2005","unstructured":"Emery RW, Krogh CC, Arom KV et\u00a0al (2005) The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 79:776\u2013783","journal-title":"Ann Thorac Surg"},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mtc.2003.53","volume":"125","author":"GL Grunkemeier","year":"2003","unstructured":"Grunkemeier GL, Wu YX (2003) \u201cOur complication rates are lower than theirs\u201d: statistical critique of heart valve comparisons. J Thorac Cardiovasc Surg 125:290\u2013300","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0003-4975(01)02656-X","volume":"72","author":"H Koertke","year":"2001","unstructured":"Koertke H, Koertke R (2001) International standardized ratio self-management after mechanical valve replacement: is an early start advantageous. Ann Thorac Surg 72:44\u201348","journal-title":"Ann Thorac Surg"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2006.05.021","volume":"48","author":"RO Bonow","year":"2006","unstructured":"Bonow RO, Carabello BA, Chatterjee K et\u00a0al (2006) ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 48:1\u2013148","journal-title":"J Am Coll Cardiol"},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/eurheartj\/ehi426","volume":"26","author":"EG Buchart","year":"2005","unstructured":"Buchart EG, Gohlke-Barwolfe C, Antunes MJ et\u00a0al (2005) Recommendations for the improvement of patients after heart valve surgery. Eur Heart J 26:2463\u20132471","journal-title":"Eur Heart J"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR et\u00a0al (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333:11\u201317","journal-title":"N Engl J Med"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1378\/chest.126.3_suppl.457S","volume":"126","author":"DN Salem","year":"2004","unstructured":"Salem DN, Stein PD, Al-Ahmed A et\u00a0al (2004) Antithrombotic therapy in valvular heart disease \u2013 native and prosthetic: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:4575\u20134825","journal-title":"Chest"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1067\/mtc.2001.115238","volume":"122","author":"S Khan","year":"2001","unstructured":"Khan S, Tronto A, DeRobertis M et\u00a0al (2001) Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 122:257\u2013269","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jtcvs.2003.07.005","volume":"126","author":"JS Ikonomides","year":"2003","unstructured":"Ikonomides JS, Krantz JM, Crumblely AT et\u00a0al (2003) Twenty-year experience with the St. Jude Medical valve prosthesis. J Thorac Cardiovasc Surg 126:2022\u20132031","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR15","doi-asserted-by":"crossref","unstructured":"Buchart EG, Ionesco A, Payne N, Grobings T, Grunkemeier GL, Fraser AG (2003) A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 108(Suppl II):II-68-2-74","DOI":"10.1161\/01.cir.0000087383.62522.1e"},{"issue":"Suppl III","key":"105_CR16","first-page":"61","volume":"84","author":"EG Buchart","year":"1991","unstructured":"Buchart EG, Lewis PA, Bethel JA et\u00a0al (1991) Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Circulation 84(Suppl III):61\u201369","journal-title":"Circulation"},{"key":"105_CR17","first-page":"1","volume":"4","author":"EG Buchart","year":"1995","unstructured":"Buchart EG, Moreno de la Santa P, Rooney ST et\u00a0al (1995) Arterial risk factors in cerebrovascular events following aortic valve replacement. J Heart Valve Dis 4:1\u20138","journal-title":"J Heart Valve Dis"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1378\/chest.126.3_suppl.287S","volume":"126","author":"MN Levine","year":"2004","unstructured":"Levine MN, Raskob G, Beyth RJ, Kearen C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment. Chest 126:2875\u20133105","journal-title":"Chest"},{"key":"105_CR19","first-page":"291","volume":"2","author":"D Horstkette","year":"1993","unstructured":"Horstkette D, Schulte H, Bircks W et\u00a0al (1993) Unsuspected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow-up of patients with St. Jude Medical prosthesis. J Heart Valve Dis 2:291\u2013301","journal-title":"J Heart Valve Dis"},{"issue":"Suppl II","key":"105_CR20","first-page":"75","volume":"108","author":"H Koertke","year":"2003","unstructured":"Koertke H, Minari K, Boethig D et\u00a0al (2003) INR self management permits lower anticoagulant levels after mechanical heart valve replacement. Circulation 108(Suppl II):75\u201378","journal-title":"Circulation"},{"key":"105_CR21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mtc.2002.121162","volume":"123","author":"EG Buchart","year":"2002","unstructured":"Buchart EG, Payne N, Li HH et\u00a0al (2002) Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 123:715\u2013723","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.athoracsur.2006.08.036","volume":"83","author":"H Koertke","year":"2007","unstructured":"Koertke H, Ziherman A, Wagner O, Koerfer R (2007) Self-management of oral anticoagulant improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg 83:24\u201329","journal-title":"Ann Thorac Surg"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0003-4975(03)00016-X","volume":"75","author":"RW Emery","year":"2003","unstructured":"Emery RW, Erickson CA, Arom KV et\u00a0al (2003) Replacement of the aortic valve in patients under 50\u00a0years of age: long term follow-up of the St. Jude Medical prosthesis. Ann Thorac Surg 75:1815\u20131819","journal-title":"Ann Thorac Surg"},{"key":"105_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-5223(19)38137-1","volume":"78","author":"RW Emery","year":"1979","unstructured":"Emery RW, Nicoloff DM (1979) St. Jude Medical cardiac valve prosthesis: in vitro studies. J Thorac Cardiovasc Surg 78:269\u2013276","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1067\/mhj.2001.115492","volume":"141","author":"RC Becker","year":"2001","unstructured":"Becker RC, Eisenberg P, Turpie AG (2001) Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: fundamental principles and the contribution of platelets and thrombin. Am Heart J 141:1025\u20131035","journal-title":"Am Heart J"},{"key":"105_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1115\/1.429634","volume":"122","author":"D Bluestein","year":"2000","unstructured":"Bluestein D, Rambod E, Gharib M (2000) Vortex shearing as a mechanism for free emboli formation in mechanical heart valves. J Biomech Eng 122:125\u2013134","journal-title":"J Biomech Eng"},{"key":"105_CR27","unstructured":"Garcia-Rinaldi R (2004) Clopidogrel \u2013 ASA combination inhibits the thrombogenicity of St. Jude Medical mechanical aortic prosthesis. CTS Net Report, September"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AG Turpie","year":"1993","unstructured":"Turpie AG, Gent M, Larpacis A et\u00a0al (1993) A comparison of aspirin with placeron patients treated with warfarin after heart valve replacement. N Engl J Med 329:524\u2013525","journal-title":"N Engl J Med"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-5223(19)35872-6","volume":"92","author":"RS Hartz","year":"1986","unstructured":"Hartz RS, LaCicero J, Kucich V et\u00a0al (1986) Comparative study of warfarin versus anti-platelet therapy in patients with a St. Jude Medical valve in the aortic position. J Thorac Cardiovasc Surg 92:684\u2013690","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0049-3848(03)00143-9","volume":"109","author":"A Schlitt","year":"2003","unstructured":"Schlitt A, Von Bardelesen RS, Ehrlich A et\u00a0al (2003) Clopidogrel and ASA in the prevention of thromboembolic complications after mechanical aortic heart valve replacement. Thromb Res 109:131\u2013135","journal-title":"Thromb Res"},{"key":"105_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.91.4.503","volume":"91","author":"LSC Czer","year":"1987","unstructured":"Czer LSC, Matloff JM, Chaux A, DeReberds RN, Gray RJ (1987) Comparative clinical experience with porcine bioprosthetic and St. Jude valve replacement. Chest 91:503\u2013514","journal-title":"Chest"},{"key":"105_CR32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-5223(19)35872-6","volume":"92","author":"PA Rebeiro","year":"1986","unstructured":"Rebeiro PA, Al-Zaibag M, Idris M et\u00a0al (1986) Anti-platelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with pneumatic heart disease. J Thorac Cardiovasc Surg 92:684\u2013690","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR33","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Rydea LT, Cannon DS et\u00a0al (2006) ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2013 executive summary. Circulation 114:700\u2013752","journal-title":"Circulation"},{"key":"105_CR34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0735-1097(00)01135-9","volume":"37","author":"D Massel","year":"2001","unstructured":"Massel D, Little SH (2001) Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 37:869\u2013878","journal-title":"J Am Coll Cardiol"},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0003-4975(02)04162-0","volume":"75","author":"M Carrier","year":"2003","unstructured":"Carrier M, Hebert Y, Pellerin M et\u00a0al (2003) Tricuspid valve replacement: an analysis of 25\u00a0years of experience at a single center. Ann Thorac Surg 75:47\u201350","journal-title":"Ann Thorac Surg"},{"key":"105_CR36","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.athoracsur.2004.12.028","volume":"79","author":"CH Kang","year":"2005","unstructured":"Kang CH, Ahn H, Kim KH, Kim KB (2005) Long-term result of 1144 carbomedics mechanical valve implants. Ann Thorac Surg 79:1939\u20131944","journal-title":"Ann Thorac Surg"},{"key":"105_CR37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.athoracsur.2004.12.019","volume":"80","author":"F Filsoufi","year":"2005","unstructured":"Filsoufi F, Anyanwu AC, Salzberg SP et\u00a0al (2005) Long-term outcomes of tricuspid valve replacement in the modern era. Ann Thorac Surg 80:845\u2013850","journal-title":"Ann Thorac Surg"},{"issue":"Suppl","key":"105_CR38","first-page":"2278","volume":"9","author":"EG Buchart","year":"1994","unstructured":"Buchart EG, Moreno de la Santa P, Rooney ST, Lewis SA (1994) The role of risk factors and trigger factors in cerebrovascular events after mitral valve replacement: implication for antithrombotic management. J Card Surg 9(Suppl):2278\u20132236","journal-title":"J Card Surg"},{"key":"105_CR39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.athoracsur.2003.10.015","volume":"77","author":"G Rizzoli","year":"2004","unstructured":"Rizzoli G, Vendramin I, Nesseris G et\u00a0al (2004) Biological or mechanical prosthesis in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg 77:1107\u20131614","journal-title":"Ann Thorac Surg"},{"key":"105_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-142-1-200501040-00006","volume":"142","author":"B Menendez-Jandula","year":"2005","unstructured":"Menendez-Jandula B, Souto JC, Oliver J et\u00a0al (2005) Comparing self-management of oral anticoagulation with clinic management. Ann Intern Med 142:1\u201310","journal-title":"Ann Intern Med"},{"key":"105_CR41","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0003-4975(01)03049-1","volume":"72","author":"P Sidhu","year":"2001","unstructured":"Sidhu P, O\u2019Kane HO (2001) Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 72:1523\u20131527","journal-title":"Ann Thorac Surg"},{"key":"105_CR42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-5223(19)34286-2","volume":"98","author":"KV Arom","year":"1989","unstructured":"Arom KV, Nicoloff DM, Kersten TE et\u00a0al (1989) Ten year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 98:1008\u20131016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5223(97)70264-2","volume":"113","author":"SS Meschengieser","year":"1997","unstructured":"Meschengieser SS, Fondevila CG, Frontroth J, Sandarelli MT, Lazzari MA (1997) Low-intensity oral anti-coagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical heart valves. J Thorac Cardiovasc Surg 113:910\u2013916","journal-title":"J Thorac Cardiovasc Surg"},{"key":"105_CR44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1378\/chest.95.3.512","volume":"95","author":"J Hirsh","year":"1989","unstructured":"Hirsh J, Salzman EW, Harker L et\u00a0al (1989) Aspirin and other anti-platelet active drugs: relationship among dose, effectiveness and side effects. Chest 95:512\u2013518","journal-title":"Chest"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0105-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-007-0105-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0105-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T03:23:09Z","timestamp":1588130589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-007-0105-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s11239-007-0105-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,4]]}}}